This program of work involves both qualitative and quantitative studies exploring attitudes, utility and experiences with the Anti-Mullerian Hormone (AMH) test. This project aims to increase evidence-based and patient-centred care, and reduce the use of unnecessary tests and treatments.

Led by: Dr Tessa Copp

Collaborators: Jenny Doust (University of Queensland), Ben Mol (Monash University), Karin Hammarberg (Monash University), Sarah Lensen (University of Melbourne), Devora Lieberman (City Fertility, Sydney CBD)